ABSTRACT. Two field isolates of feline herpesvirus type 1 (FHV-1) designated as 00-015 and 00-035, were obtained from cats diagnosed as feline viral rhinotracheitis (FVR) in Japan. To analyze the character of recent FHV-1, these two isolates and our laboratory strain C7301 were inoculated experimentally to specific-pathogen-free cats. Although all cats showed typical FVR symptoms, more severe clinical symptoms were observed on cats infected with the isolates 00-015 and 00-035 compared with those of C7301-infected cats. Severe ocular lesions including conjunctivitis were found in the cats infected with the isolates, indicating that the recent FHV-1 has a potential to induce severe FVR symptoms including ocular lesions. KEY WORDS: conjunctivitis, feline herpesvirus type 1, feline viral rhinotracheitis.
Feline herpesvirus type 1 (FHV-1), a member of the subfamily Alphaherpesvirinae of the family Herpesviridae, causes an upper respiratory tract disease known as feline viral rhinotracheitis (FVR), characterized by upper respiratory symptoms such as sneezing, ocular and nasal discharges, and conjunctivitis [20, 30, 32, 33, 35] . Infection in newborn or debilitated cats with FHV-1 can result in a severe generalized disease with high mortality rate [32] . Most of cats that recover from acute FHV-1 infection become viral carriers [14] .
In 1958, FHV-1 was first isolated from kittens showing an upper respiratory syndrome. This original isolate, designated as C-27, is the prototype strain of FHV-1 [4] . Since then, many FHV-1 strains have been isolated and the clinical, virological, immunological and pathological features on FVR have been reported [8-12, 16, 19, 21-27, 29, 37] . We classified various field isolates of FHV-1 into 3 genotypes (F2, C7301 and C7805) using restriction endonuclease MluI cleavage pattern [22] . In the study, 8 of 80 field isolates were revealed to be the genotype of the attenuated vaccine strain F2. However, the pathogenicity of these genotypes is still to be analyzed.
In 2000, two isolates of FHV-1 (00-015 and 00-035) were obtained from ocular discharges of cats diagnosed as FVR in Tokyo and Chiba Prefecture in Japan. These cats showed severe upper respiratory tract symptoms and conjunctivitis. In both cases, feline calicivirus and Chlamydia psittaci were not detected in the ocular swab samples by the methods described previously [27] . To evaluate the pathogenicity of these strains in vivo, we inoculated the two isolates and our laboratory strain C7301 [25] to specificpathogen-free (SPF) cats.
The field isolates were propagated less than five times in Crandell feline kidney (CRFK) cell cultures [6] . MluI cleavage patterns of the genome of the isolates were determined by the methods described by Horimoto et al. [16] . The cells were grown in Dulbecco's modified Eagle's minimum essential medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS) and antibiotics. The maintenance medium for harvesting the virus was free from FCS.
To determine the titer of each FHV-1 strain, CRFK cells were prepared on 24-well plates and inoculated with 0.2 ml of each virus sample diluted from 10 -3 to 10 -8 . After 60-min adsorption, the cells were washed twice with DMEM, and then added DMEM containing 2% FCS and 1% agarose (FMC Bio Products, U. S. A.). They were incubated at 37°C in a CO 2 incubator for 5 days. When cytopathic effect (CPE) was observed, the cells were fixed by phosphatebuffered formalin, and followed by staining with crystal violet. Plaques were counted and each viral titer was determined.
A total of 6 SPF cats (Harlan Sprague Dawley, Inc., U.S.A.) of approximately 3 months of age were divided into three groups. Each group (n=2) was kept in a separated cage. Before inoculation, serum samples were collected and analyzed for anti-FHV-1 antibody by enzyme-linked immunosorbent assay (ELISA). Each group was inoculated once intraocularly and intranasally with 1.0 ml of viral fluid containing 1.0 × 10 6 plaque-forming units (PFU) of each strain per a cat. Sera were collected on 0, 7, 14, 21, 28 days post inoculation (DPI) and stored at -20°C until use. Rectal temperature and body weight were recorded daily for 28 days. Clinical signs were scored on the basis of 1 point (mild) and 2 points (severe) using the modified scoring system [40] as shown in Table 1 .
To test viral shedding, ocular, nasal and oral secretion samples were collected on 0, 4, 7, 10, 14, 17, 21, 24, 28 DPI with sterile cotton swabs. After each swab was transferred into a sterile tube containing 2.0 ml of DMEM and the tube was shaken vigorously, the medium was centrifuged at low speed. Then the supernatant was collected and stored at -80°C until use. After the dilution of samples from 10 0 to 10 -7 in DMEM, 50 µl of them were poured into 96-well microtiter plates and a suspension of CRFK cells was added in each well. CPE was monitored for 7 days and virus titers were calculated as TCID 50 /50 µl.
For ELISA, FHV-1-infected or mock-infected CRFK cells were collected, washed twice with phosphate-buffered saline (PBS) and then lysed in lysis buffer (1% Triton X-100, 1% sodium deoxycholic acid, 0.01 M Tris-HCl (pH 8.0), 0.14 M NaCl and 0.025% NaN 3 ). After the lysate was centrifuged, the supernatant was used as the antigen. Each well of a 96-well flat-bottom ELISA plate (Maxisorp, Nunc, Denmark) was coated with the antigen solution at 4°C overnight. After blocking, they were washed with PBS containing 0.05% Tween-20 (PBST). The infected-cat's serum at a dilution of 1:100 with PBST containing 1% gelatin was added to each well. After incubation and washing, the anticat IgG goat antibody conjugated with horseradish peroxidase (EY Laboratories Inc., U.S.A.) were reacted. After washing with PBST, the wells were reacted with TMB Peroxidase EIA Substrate Kit (Bio-Rad Laboratories, U.S.A.). The reaction was stopped by 1N H 2 SO 4 . The optical density was measured at 450 nm with an ELISA reader (Bio-Rad Laboratories, Model 2550, U.S.A.). ELISA absorbance was calculated by subtracting an optical density of each serum sample with the mock-infected antigen from that with FHV-1 infected antigen.
To evaluate the pathogenicity of new isolates in vivo, we inoculated 00-015, 00-035 or C7301 to SPF cats. After inoculation, all groups showed typical clinical symptoms of FVR from the onset of disease characterized sneezing, nasal discharge, and heavy respiration as scores shown in Table 2 . Although there was no significant difference in the scores for sneezing and heavy respiration among the groups, a cat infected with 00-035 (No. 6) had the most severe nasal discharge among the infected cats. The cat developed nasal hemorrhage on 8 DPI (Fig. 1A) . Ocular discharge and conjunctivitis were also observed in all groups. The scores for conjunctivitis of C7301-infected cat were 1 and 4, while those of 00-015-cats were 3 and 28 and those of 00-035-cats were 10 and 30 ( Table 2 ). No. 3 cat infected with 00-035 developed especially severe conjunctivitis on 8 DPI (Fig. 1B) . The clinical scores for ocular discharge in 00-015-and 00-035-infected cats showed a tendency to be higher than those in C7301-infected cats ( Table 2 ). The total clinical scores of 00-035-infected cats and one of 00-015-infected cats were higher than those of C7301-infected cats.
The rectal temperature of all cats elevated over 39.5°C on 4 or 5 DPI (Fig. 2A) . Most of the cats (No. 1, 2, 4 and 6) showed a bimodal pattern of fever. However, no clear difference on the degree of the fever was observed among the groups. Although a cat (No. 1) kept its body weight recorded on 0 DPI even after the onset of disease, the body weight of the other cats decreased to approximately 90% (No. 2 to 4) and 80% (No. 5 and 6). The decrease of body weight of 00-015-or 00-035-infected cats seemed more severe than that of C7301-infected cats.
Virus titer was measured for ocular, nasal and oral swab samples of each cat. Virus titer of all cats increased rapidly after inoculation, peaked on 7 DPI and decreased promptly until 14 DPI (data not shown). The antibodies were not detected by ELISA or very low until 7 DPI, and then increased rapidly by 14 DPI in all the cats (Fig. 3) . It was suggested that the virus clearance occurred rapidly in the cats by their immune response against FHV-1, including anti-FHV-1 antibody production. All cats were scored using the point system [40] .
We observed more severe conjunctivitis and ocular discharge on cats (No. 3 and 5) infected with recent field isolates of 00-035 and 00-015, compared with those caused by our laboratory strain C7301. Conjunctivitis and rhinotracheitis are the most common clinical symptoms in natural infection of FHV-1 [13, 34] . Although experimental infections were performed using various FHV-1 isolates, severe ocular clinical manifestation have been rarely reported in experimentally infected cats [14, 20, 25, 26, 36, [38] [39] [40] [41] . The clinical scores in cats infected with C7301 were very similar to those in the previous reports using other FHV-1 strains [5, 17, 18, 31, [39] [40] [41] , indicating that C7301 strain keeps its pathogenicity as well as the other well-characterized strains and that high-passage history of C7301 does not seem to influence its virulence. Therefore, these results in this study indicated that the recent isolates would be more virulent than the well-characterized strains such as our laboratory strain C7301.
Since we used SPF cats in this study, these cats recovered from experimental infection without developing secondary infection, which is one of the serious problems in field cats infected with FHV-1. Most of the cats infected with FHV-1, generally recover from FVR unless secondary infection or marked debilitation occurs [1] . Therefore, these recent isolates in this study might induce more severe FVR symptoms including ocular lesions to field cats. In fact, 00-015 was isolated from the cat which died of dyspnea caused by severe rhinotracheitis. Further epidemiological study will be required to clarify the pathogenesis of recent FHV-1 infections.
Interestingly, we found that the isolate 00-015 is classified into the F2 genotype by the endonuclease MluI cleavage patterns, while the isolate 00-035 belongs to the C7301 genotype (data not shown), indicating that the F2 genotype is as virulent as C7301 genotype and that the digestion pattern with restriction endonuclease MluI is not likely to correlate with viral pathogenicity. Alternative marker to differentiate the vaccine F2 strain from FHV-1 field isolates will be needed.
